Prognostic Value of Subependymal Enhancement on Baseline MRI in Primary Central Nervous System Lymphoma.

Kim D, Chung DS, Yoon WS

DOI: 10.3390/cancers18182906
Published: 2026 Sep 8
Container: Cancers
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/cancers18182906,
  title = {Prognostic Value of Subependymal Enhancement on Baseline MRI in Primary Central Nervous System Lymphoma.},
  author = {Kim D and Chung DS and Yoon WS},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18182906},
  url = {https://doi.org/10.3390/cancers18182906}
}

RIS

TY  - JOUR
TI  - Prognostic Value of Subependymal Enhancement on Baseline MRI in Primary Central Nervous System Lymphoma.
AU  - Kim D
AU  - Chung DS
AU  - Yoon WS
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18182906
UR  - https://doi.org/10.3390/cancers18182906
ER  -

APA

D, K., DS, C., & WS, Y. (2026). Prognostic Value of Subependymal Enhancement on Baseline MRI in Primary Central Nervous System Lymphoma.. Cancers. https://doi.org/10.3390/cancers18182906

Source records

pubmed · retrieved 2026-09-26T17:06:21.647Z